학술논문
Comparison of consistency and complementarity of reporting biosimilar quality attributes between regulatory and scientific communities: An adalimumab case study
Document Type
Article
Author
Source
In Biologicals January 2021 69:30-37
Subject
Language
ISSN
1045-1056